Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Pancreatic Neoplasms 7 Colorectal Neoplasms 5 Breast Neoplasms 5 Prostatic Neoplasms 4 COVID-19 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Lung Neoplasms 2 Cholangiocarcinoma 2 Untreated Resectable Pancreatic Adenocarcinoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Peripheral Nervous System Diseases 1 Pancreatic Cancer Resectable 1 Neoplasm, Residual 1 Liver Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Klatskin Tumor 1 Hypoxia 1 Hematologic Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 41 fludarabine 35 Tacrolimus 28 Mycophenolic Acid 27 Whole-Body Irradiation 25 Busulfan 24 fludarabine phosphate 21 Melphalan 19 thymoglobulin 16 Antilymphocyte Serum 16 Methotrexate 13 Thiotepa 12 Stem Cell Transplantation 9 Rituximab 9 Granulocyte Colony-Stimulating Factor 9 Filgrastim 8 Cyclosporine 8 trametinib 7 Sirolimus 7 Nivolumab 5 ruxolitinib 4 merphos 4 Peripheral Blood Stem Cell Transplantation 4 Cytarabine 4 Cord Blood Stem Cell Transplantation 4 Bendamustine Hydrochloride 4 tocilizumab 3 itacitinib 3 fedratinib 3 dabrafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × Hydroxychloroquine × Clear all

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡